The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Clusterin inhibits apoptosis by interacting with activated Bax
Abstract
Clusterin is an enigmatic glycoprotein that is overexpressed in several human cancers such as prostate and breast cancers, and squamous cell carcinoma. Because the suppression of clusterin expression renders human cancer cells sensitive to chemotherapeutic drug-mediated apoptosis, it is currently an antisense target in clinical trials for prostate cancer. However, the molecular mechanisms by which clusterin inhibits apoptosis in human cancer cells are unknown. Here we report that intracellular clusterin inhibits apoptosis by interfering with Bax activation in mitochondria. Intriguingly, in contrast to other inhibitors of Bax, clusterin specifically interacts with conformation-altered Bax in response to chemotherapeutic drugs. This interaction impedes Bax oligomerization, which leads to the release of cytochrome c from mitochondria and caspase activation. Moreover, we also find that clusterin inhibits oncogenic c-Myc-mediated apoptosis by interacting with conformation-altered Bax. Clusterin promotes c-Myc-mediated transformation in vitro and tumour progression in vivo. Taken together, our results suggest that the elevated level of clusterin in human cancers may promote oncogenic transformation and tumour progression by interfering with Bax pro-apoptotic activities.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“CLU gene encodes clusterin or APOJ that besides its functions in lipid transport, membrane recycling, cell adhesion, and apoptosis (90, 444, 600, 677) affects transvascular A 𝛃 clearance by promoting A 𝛃 42 efflux across the BBB (580).”
From Blood-Brain Barrier: From Physiology to Disease and Back (2019) · cites this paper as [677]
Citations
Cites
1 retracted
Ku70 suppresses the apoptotic translocation of Bax to mitochondria
Sawada, M., Sun, W., Hayes, P. L., Leskov, K., Boothman, D. A., & Matsuyama, S. (2003) · Nature Cell Biology · doi:10.1038/ncb950 · Cited by 353
RetractedCleavage of BID by Caspase 8 Mediates the Mitochondrial Damage in the Fas Pathway of Apoptosis
Li, H., Zhu, H., Xu, C.-J., & Yuan, J. (1998) · Cell · doi:10.1016/s0092-8674(00)81590-1 · Cited by 4,445
Proapoptotic BAX and BAK: A Requisite Gateway to Mitochondrial Dysfunction and Death
Wei, M. C., Zong, W.-X., Cheng, E. H.-Y., Lindsten, T., Panoutsakopoulou, V., Ross, A. J., Roth, K. A., MacGregor, G. R., Thompson, C. B., & Korsmeyer, S. J. (2001) · Science · doi:10.1126/science.1059108 · Cited by 3,988
Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells
Vaux, D., Cory, S., & Adams, J. (1988) · Nature · doi:10.1038/335440a0 · Cited by 3,355
(2001) · PubMed · Cited by 2,381
Cheng, E. H. Y., Wei, M. C., Weiler, S., Flavell, R. A., Mak, T. W., Lindsten, T., & Korsmeyer, S. J. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00320-3 · Cited by 1,735
Bid, Bax, and Lipids Cooperate to Form Supramolecular Openings in the Outer Mitochondrial Membrane
Kuwana, T., Mackey, M. R., Perkins, G. A., Ellisman, M. H., Latterich, M., Schneiter, R., Green, D. R., & Newmeyer, D. D. (2002) · Cell · doi:10.1016/s0092-8674(02)01036-x · Cited by 1,513
Wang, S., Gao, J., Lei, Q., Rozengurt, N., Pritchard, C., Jiao, J., Thomas, G. V., Li, G., Roy-Burman, P., Nelson, P. S., et al. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00215-0 · Cited by 1,109
Apoptotic cell death induced by c-myc is inhibited by bcl-2
Bissonnette, R. P., Echeverri, F., Mahboubi, A., & Green, D. R. (1992) · Nature · doi:10.1038/359552a0 · Cited by 957
Zong, W., Lindsten, T., Ross, A. J., MacGregor, G. R., & Thompson, C. B. (2001) · Genes & Development · doi:10.1101/gad.897601 · Cited by 809
Flagged first, then by citations
Cited by
Sorted by citations
Items 201–300 of 451
Mohapatra, S., Chu, B., Zhao, X., Djeu, J. Y., Cheng, J. Q., & Pledger, W. J. (2008) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2008.07.013 · Cited by 28
Crochiere, M. L., Kashyap, T., Kalid, O., Shechter, S., Klebanov, B., Senapedis, W. T., Saint‐Martin, J., & Landesman, Y. (2015) · BMC Cancer · doi:10.1186/s12885-015-1790-z · Cited by 28
Abramovitch‐Dahan, C., Asraf, H., Bogdanovic, M., Sekler, I., Bush, A. I., & Hershfinkel, M. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13760 · Cited by 28
Dabbs, R. A., Wyatt, A. R., Yerbury, J. J., Ecroyd, H. W., & Wilson, M. R. (2011) · Topics in current chemistry · doi:10.1007/128_2011_262 · Cited by 28
Expression of the Antiapoptotic Proteins Clusterin and Bcl-2 in Laryngeal Squamous Cell Carcinomas
Redondo, M., Esteban, F., Gonzalez-moles, M. A., Delgado‐Rodríguez, M., Nevado, M., Torres-Muñoz, J., Téllez, T., Villar, E., Morell, M., & Petito, C. K. (2006) · Tumor Biology · doi:10.1159/000093055 · Cited by 28
Potential use of custirsen to treat prostate cancer
Higano, C. S. (2013) · OncoTargets and Therapy · doi:10.2147/ott.s33077 · Cited by 30
Song, H., Zhou, H., Qu, Z., Hou, J., Chen, W., Cai, W.-W., Cheng, Q., Chuang, D. Y., Chen, S., Li, S., et al. (2018) · Translational Stroke Research · doi:10.1007/s12975-018-0675-2 · Cited by 27
Genetic Insights into the Impact of Complement in Alzheimer’s Disease
Torvell, M., Carpanini, S. M., Daskoulidou, N., Byrne, R. A. J., Sims, R., & Morgan, B. P. (2021) · Genes · doi:10.3390/genes12121990 · Cited by 29
Direct Interaction of Selenoprotein R with Clusterin and Its Possible Role in Alzheimer’s Disease
Chen, P., Wang, C., Ma, X., Zhang, Y., Liu, Q., Qiu, S., Liu, Q., Tian, J., & Ni, J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0066384 · Cited by 27
Self-citationKlokov, D. Y., Leskov, K., Araki, S., Zou, Y., Goetz, E. M., Luo, X., Willson, D., & Boothman, D. A. (2012) · Oncogene · doi:10.1038/onc.2012.64 · Cited by 27
The potential of clusterin inhibiting antisense oligodeoxynucleotide therapy for prostate cancer
Miyake, H., Hara, I., Fujisawa, M., & Gleave, M. E. (2006) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.15.5.507 · Cited by 27
Fabián, O., Bajer, L., Drastich, P., Harant, K., Sticová, E., Ďásková, N., Módos, I., Tichánek, F., & Cahová, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24119386 · Cited by 27
Chapter 7 Cell Protective Functions of Secretory Clusterin (sCLU)
Klock, G., Baiersdörfer, M., & Koch-Brandt, C. (2009) · Advances in cancer research · doi:10.1016/s0065-230x(09)04007-x · Cited by 27
The role of clusterin in prostate cancer: treatment resistance and potential as a therapeutic target
Muhammad, L. A., & Fred Saad, C. (2015) · Expert Review of Anticancer Therapy · doi:10.1586/14737140.2015.1064769 · Cited by 26
van Luijn, M. M., van Meurs, M., Stoop, M. P., Verbraak, E., Wierenga‐Wolf, A. F., Melief, M., Kreft, K. L., Verdijk, R. M., Hart, B. A. ‘., Luider, T. M., et al. (2015) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlv004 · Cited by 26
Tissue-specific activities of the Fat1 cadherin cooperate to control neuromuscular morphogenesis
Helmbacher, F. (2018) · PLoS Biology · doi:10.1371/journal.pbio.2004734 · Cited by 26
Protective effect of clusterin on rod photoreceptor in rat model of retinitis pigmentosa
Vargas, A., Kim, H. S., Baral, E., Yu, W., Craft, C. M., & Lee, E.-J. (2017) · PLoS ONE · doi:10.1371/journal.pone.0182389 · Cited by 25
Neuronal hibernation following hippocampal demyelination
Baltan, S., Jawaid, S., Chomyk, A. M., Kidd, G. J., Chen, J. M., Battapady, H. D., Chan, R., Dutta, R., & Trapp, B. D. (2021) · Acta Neuropathologica Communications · doi:10.1186/s40478-021-01130-9 · Cited by 25
Tan, J., Guo, W., Yang, S., Han, D., & Li, H. (2021) · Translational Lung Cancer Research · doi:10.21037/tlcr-20-1298 · Cited by 25
The Ins and Outs of Clusterin: Its Role in Cancer, Eye Diseases and Wound Healing
Gross, C., Guérin, L.-P., Socol, B. G., Germain, L., & Guérin, S. L. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241713182 · Cited by 25
Heat shock and other apoptosis-related proteins as therapeutic targets in prostate cancer
Hahn, N., & Albany, C. (2014) · Asian Journal of Andrology · doi:10.4103/1008-682x.126400 · Cited by 25
Zielinski, R., & Chi, K. N. (2012) · Future Oncology · doi:10.2217/fon.12.129 · Cited by 25
PACAP inhibits tumor growth and interferes with clusterin in cervical carcinomas
Lee, J., Lee, J., Rho, S. B., Choi, J., Lee, D., An, S., Oh, T., Choi, D., & Lee, S. (2014) · FEBS Letters · doi:10.1016/j.febslet.2014.11.004 · Cited by 25
Multiple pathways regulating the anti-apoptotic protein clusterin in breast cancer
Ranney, M., Ahmed, I., Potts, K. R., & Craven, R. J. (2007) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2007.06.004 · Cited by 25
Horizon scanning for novel therapeutics for the treatment of prostate cancer
Bianchini, D., Zivi, A., Sandhu, S. K., & Bono, J. S. D. (2010) · Annals of Oncology · doi:10.1093/annonc/mdq369 · Cited by 24
Xu, Y., Wu, D., Zheng, W., Yu, F., Yang, F., Yao, Y., Zhou, Y., Ching, Y.-P., & Lau, A. T. Y. (2015) · Oncotarget · doi:10.18632/oncotarget.6738 · Cited by 24
Clusterin/apolipoprotein J, its isoforms and Alzheimer's disease
Milinkeviciute, G., & Green, K. N. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1167886 · Cited by 24
The Role of Clusterin (CLU) in Malignant Transformation and Drug Resistance in Breast Carcinomas
Redondo, M., Téllez, T., & Tapia, M. J. (2009) · Advances in cancer research · doi:10.1016/s0065-230x(09)05002-7 · Cited by 24
Polimeno, L., Rossi, R., Mastrodonato, M., Montagnani, M., Piscitelli, D., Pesetti, B., Benedictis, L. D., Girardi, B., Resta, L., Napoli, A., et al. (2013) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2013.07.010 · Cited by 24
Lee, D., Ha, J., Kim, Y., Bae, K., Park, J., Choi, W. S., Yoon, H. S., Park, S. G., Park, B. C., Yi, G.-S., et al. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.04.054 · Cited by 24
Moore, R. A., Sturdevant, D. E., Chesebro, B. W., & Priola, S. A. (2014) · Journal of Proteome Research · doi:10.1021/pr500329w · Cited by 24
Rodríguez-Piñeiro, A. M., García-Lorenzo, A., Blanco-Prieto, S., Álvarez-Chaver, P., Rodrı́guez-Berrocal, F. J., de la Cadena, M. P., & Martínez-Zorzano, V. S. (2012) · Cancer Investigation · doi:10.3109/07357907.2011.630051 · Cited by 24
Clusterin, a Novel DEC1 Target, Modulates DNA Damage–Mediated Cell Death
Ming, X., Bao, C., Hong, T., Yang, Y., Chen, X., Jung, Y.-S., & Qian, Y. (2018) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-18-0070 · Cited by 23
Mu, L.-H., Yang, F., Guo, D. S., Li, P., & Zhang, M. (2020) · Bioengineered · doi:10.1080/21655979.2020.1747825 · Cited by 23
Liu, Y., Zhou, Y., Ma, X., & Chen, L. (2021) · Advanced Science · doi:10.1002/advs.202003205 · Cited by 23
Clusterin Deficiency Exacerbates Hyperoxia-Induced Acute Lung Injury
Hong, J. Y., Kim, M. N., Kim, E. G., Lee, J. W., Kim, H. R., Kim, S. Y., Lee, S. M., Kim, Y. H., Kim, K. W., & Sohn, M. H. (2021) · Cells · doi:10.3390/cells10040944 · Cited by 23
He, L., Liu, M., Li, B., Rao, H., Liao, Y.-J., Zhang, L., Guan, X., Zeng, Y., & Xie, D. (2009) · Cancer Science · doi:10.1111/j.1349-7006.2009.01349.x · Cited by 23
Antonelou, M. H., Kriebardis, A. G., Stamoulis, K. E., Trougakos, I. P., & Papassideri, I. S. (2011) · PLoS ONE · doi:10.1371/journal.pone.0026033 · Cited by 23
Tomazic, P. V., Birner‐Gruenberger, R., Leitner, A., Spoerk, S., & Lang‐Loidolt, D. (2015) · Journal of Proteomics · doi:10.1016/j.jprot.2015.12.021 · Cited by 23
Arumugam, P., Samson, A. A. S., Ki, J., & Song, J. M. (2017) · Cell Biology and Toxicology · doi:10.1007/s10565-016-9378-1 · Cited by 23
Kim, M. J., Choi, M. Y., Lee, D. H., Roh, G. S., Kim, H. J., Kang, S. S., Cho, G. J., Kim, Y. S., & Choi, W. S. (2017) · Oncotarget · doi:10.18632/oncotarget.23588 · Cited by 23
Characterisation of the Bax-nucleophosmin interaction: the importance of the Bax C-terminus
Thompson, J., Finlayson, K., Salvo‐Chirnside, E., MacDonald, D., McCulloch, J., Kerr, L. E., & Sharkey, J. (2008) · APOPTOSIS · doi:10.1007/s10495-007-0177-2 · Cited by 23
COVID ‐19 and neurodegeneration: The mitochondrial connection
Denaro, C. A., Haloush, Y. I., Hsiao, S. Y., Orgera, J. J., Osorio, T., Riggs, L. M., Sassaman, J. W., Williams, S. A., Carlo, A. R. M., da Costa, R. T., et al. (2022) · Aging Cell · doi:10.1111/acel.13727 · Cited by 23
Blumenstein, B. A., Fred Saad, C., Hotte, S. J., Chi, K. N., Eigl, B. J., Gleave, M. E., & Jacobs, C. A. (2013) · Cancer Medicine · doi:10.1002/cam4.93 · Cited by 22
Mukherjee, S., Jagadeeshaprasad, M. G., Banerjee, T., Ghosh, S., Biswas, M., Dutta, S., Kulkarni, M. J., Pattari, S. K., & Bandyopadhyay, A. (2014) · Clinical Proteomics · doi:10.1186/1559-0275-11-35 · Cited by 22
Song, H., Zhu, L. J., Li, Y., Ma, C., Guan, K., Xia, X., & Li, F. (2015) · Gene · doi:10.1016/j.gene.2015.07.057 · Cited by 22
Proteomics as a tool for optimization of human plasma protein separation
Kovač, S., Yang, X., Huang, F., Hixson, D. C., & Josić, D. (2008) · Journal of Chromatography A · doi:10.1016/j.chroma.2008.04.026 · Cited by 22
Relationship between sputum clusterin levels and childhood asthma
Sol, I. S., Kim, Y. H., Park, Y. A., Lee, K. E., Hong, J. Y., Kim, M. N., Kim, Y. S., Oh, M. S., Yoon, S. H., Kim, M. J., et al. (2015) · Clinical & Experimental Allergy · doi:10.1111/cea.12686 · Cited by 22
Genetic background influences murine prostate gene expression: implications for cancer phenotypes
Bianchi-Frias, D., Pritchard, C. C., Mecham, B. H., Coleman, I. M., & Nelson, P. S. (2007) · Genome biology · doi:10.1186/gb-2007-8-6-r117 · Cited by 22
Cell surface nucleolin is a novel ADAMTS5 receptor mediating endothelial cell apoptosis
Kirman, D. C., Renganathan, B., Chui, W. K., Chen, M. W., Kaya, N. A., & Ge, R. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-04618-x · Cited by 21
Janiszewska, E., Kmieciak, A., Kacperczyk, M., Witkowska, A., & Kratz, E. M. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/7657876 · Cited by 21
Grazia, G., Vegetti, C., Benigni, F., Penna, I., Perotti, V., Tassi, E., Bersani, I., Nicolini, G., Canevari, S., Carlo‐Stella, C., et al. (2014) · Cell Death and Disease · doi:10.1038/cddis.2014.410 · Cited by 22
Molecular mechanisms of the antimetastatic activity of nuclear clusterin in prostate cancer cells
Limonta, P. (2011) · International Journal of Oncology · doi:10.3892/ijo.2011.1030 · Cited by 21
Xu, M., Chen, X., Han, Y., Ma, C., Ma, L., & Li, S. (2015) · Europe PMC (PubMed Central) · Cited by 21
Lee, J., Kim, H. J., Rho, S. B., & Lee, S. (2016) · Oncotarget · doi:10.18632/oncotarget.8105 · Cited by 21
Smith, A. R., Mill, J. S., Smith, R. G., & Lunnon, K. (2016) · Neuroepigenetics · doi:10.1016/j.nepig.2016.05.001 · Cited by 21
Mechanistic implications of altered protein expression in rheumatic heart disease
Lumngwena, E. N., Skatulla, S., Blackburn, J. M., & Ntusi, N. (2020) · Heart Failure Reviews · doi:10.1007/s10741-020-09993-1 · Cited by 21
Subramanian, M., & Shaha, C. (2009) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2008.00679.x · Cited by 21
GABAB1e promotes the malignancy of human cancer cells by targeting the tyrosine phosphatase PTPN12
Wei, B., Zhu, Y., Yang, P., Han, Y. K., Wang, S., Wang, X., Xia, S., Song, X., Zhang, Z., Wang, S., et al. (2021) · iScience · doi:10.1016/j.isci.2021.103311 · Cited by 20
Clusterin: a marker and mediator of chemoresistance in colorectal cancer
Hlavca, S., Chan, W. H., Engel, R. M., & Abud, H. E. (2024) · Cancer and Metastasis Reviews · doi:10.1007/s10555-024-10173-y · Cited by 20
Yu, W., Chen, D., Wang, Z., Zhou, C., Luo, J., Xu, Y., Shen, L., Yin, H., Tao, S., Xiao, Z., et al. (2014) · Journal of Molecular Neuroscience · doi:10.1007/s12031-014-0237-3 · Cited by 20
Zinkie, S., Gentil, B. J., Minotti, S., & Durham, H. D. (2013) · Cell Stress and Chaperones · doi:10.1007/s12192-013-0427-x · Cited by 19
Xiu, P., Xu, Z., Liu, F., Li, Z., Li, T., Zou, F., Sun, X., & Li, J. (2014) · Digestive Diseases and Sciences · doi:10.1007/s10620-014-3111-9 · Cited by 18
Self-citationDetecting soluble Clusterin in in-vitro and in-vivo models of prostate cancer
Girard, F., Byrne, J., Downes, M. R., Fanning, D. M., Desgrandchamps, F., Fitzpatrick, J., & Watson, R. W. G. (2010) · Neoplasma · doi:10.4149/neo_2010_05_488 · Cited by 18
CLU rs11136000 Promotes Early Cognitive Decline in Parkinson's Disease
Sampedro, F., Marín‐Lahoz, J., Martínez‐Horta, S., Pérez‐González, R., Pagonabarraga, J., & Kulisevsky, J. (2020) · Movement Disorders · doi:10.1002/mds.27949 · Cited by 18
Inhibition of Clusterin Represses Proliferation by Inducing Cellular Senescence in Pancreatic Cancer
Mitsufuji, S., Iwagami, Y., Kobayashi, S., Sasaki, K., Yamada, D., Tomimaru, Y., Akita, H., Asaoka, T., Noda, T., Gotoh, K., et al. (2022) · Annals of Surgical Oncology · doi:10.1245/s10434-022-11668-0 · Cited by 18
Essabbani, A., Garcı́a, L., Zonetti, M. J., Fisco, T., Pucci, S., & Chiocchia, G. (2013) · PLoS ONE · doi:10.1371/journal.pone.0054920 · Cited by 18
Proteome Changes in Caco-2 Cells Treated with Monascus-Fermented Red Mold Rice Extract
Lin, W., Hsu, W.-Y., Hish, C.-H., & Pan, T. (2007) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf072197l · Cited by 18
Association between B‑Myb proto‑oncogene and the development of malignant tumors (Review)
Jin, Y., Qi, G., Chen, G., Wang, C., & Fan, X. (2021) · Oncology Letters · doi:10.3892/ol.2021.12427 · Cited by 17
Self-citationClusterin protects mature dendritic cells from reactive oxygen species mediated cell death
Malizia, Á. L., Merlotti, A., Bonté, P., Sager, M., Arribas, Y. A., Goudot, C., Díaz, F. A. E., Pereyra-Gerber, P., Ceballos, A., Amigorena, S., et al. (2023) · OncoImmunology · doi:10.1080/2162402x.2023.2294564 · Cited by 17
Iłżecka, J., Iłżecki, M., Grabarska, A., Dave, S., Feldo, M., & Zubilewicz, T. (2019) · Upsala Journal of Medical Sciences · doi:10.1080/03009734.2019.1646359 · Cited by 17
Endogenous Human Proteins Interfering with Amyloid Formation
Gharibyan, A. L., Jayaweera, S. W., Lehmann, M., Anan, I., & Olofsson, A. (2022) · Biomolecules · doi:10.3390/biom12030446 · Cited by 17
Clusterin (APOJ) in Alzheimer’s Disease: An Old Molecule with a New Role
Woody, S. K., & Zhao, L. (2016) · InTech eBooks · doi:10.5772/64233 · Cited by 17
Future Directions in Castrate-Resistant Prostate Cancer Therapy
Antonarakis, E. S., & Carducci, M. A. (2010) · Clinical Genitourinary Cancer · doi:10.3816/cgc.2010.n.006 · Cited by 16
Eriksdotter, M., Navarro-Oviedo, M., Mitra, S., Wahlberg, L. U., Linderoth, B., Tjernberg, L. O., & Behbahani, H. (2018) · Experimental Cell Research · doi:10.1016/j.yexcr.2018.08.007 · Cited by 16
The miR-181 family regulates colonic inflammation through its activity in the intestinal epithelium
Jimenez, M. T., Clark, M. L., Wright, J. M., Michieletto, M. F., Liu, S., Erickson, I., Dohnalová, L., Uhr, G. T., Cajiao, J. J. T., Joannas, L. D., et al. (2022) · The Journal of Experimental Medicine · doi:10.1084/jem.20212278 · Cited by 16
Insig2 is associated with colon tumorigenesis and inhibits Bax‐mediated apoptosis
Li, C. G., Gruidl, M., Eschrich, S. A., McCarthy, S. M., Wang, H., Alexandrow, M. G., & Yeatman, T. J. (2008) · International Journal of Cancer · doi:10.1002/ijc.23510 · Cited by 16
THE IDENTIFICATION OF SERUM BIOMARKERS OF HIGH-LET RADIATION EXPOSURE AND BIOLOGICAL SEQUELAE
Britten, R. A., Green-Mitchell, S. M., Johnson, A. M., Singletary, S. J., Keeney, S. K., Nyalwidhe, J. O., Karbassi, I., Lónárt, G., Sanford, L. D., & Drake, R. R. (2010) · Health Physics · doi:10.1097/hp.0b013e3181acff7c · Cited by 16
Zmudzinska, A., Wiśniewski, J. Ł., Młynarz, P., Olejnik, B., & Mogielnicka-Brzozowska, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23169143 · Cited by 15
Kovács, P., Pushparaj, P. N., Takács, R., Mobasheri, A., & Matta, C. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1103097 · Cited by 15
Custirsen (OGX-011): Clusterin Inhibitor in Metastatic Prostate Cancer
Al-Asaaed, S., & Winquist, E. (2012) · Current Oncology Reports · doi:10.1007/s11912-012-0285-1 · Cited by 15
Clusterin interaction with Bcl-xL is associated with seizure-induced neuronal death
Kim, Y. S., Choi, M. Y., Ryu, J. H., Lee, D. H., Jeon, B. T., Roh, G. S., Kang, S. S., Kim, H. J., Cho, G. J., & Choi, W. S. (2011) · Epilepsy Research · doi:10.1016/j.eplepsyres.2011.12.002 · Cited by 15
Unglycosylated clusterin variant accumulates in the endoplasmic reticulum and induces cytotoxicity
Kang, S., Yoon, S., Park, J., & Kim, D. (2012) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2012.11.014 · Cited by 15
Gupta, S. D., Lipponen, A., Paldanius, K. M. A., Puhakka, N., & Pitkänen, A. (2019) · Scientific Reports · doi:10.1038/s41598-019-56683-6 · Cited by 15
Genome-wide transcription analysis of histidine-related cataract in Atlantic salmon (Salmo salar L).
Tröße, C., Waagbø, R., Breck, O., Stavrum, A.-K., Petersen, K., & Olsvik, P. A. (2009) · PubMed Central · Cited by 15
Berdowska, I., Matusiewicz, M., & Krzystek‐Korpacka, M. (2022) · Antioxidants · doi:10.3390/antiox11030524 · Cited by 14
Molecular Biomarkers of Canine Reproductive Functions
Mogielnicka-Brzozowska, M., & Cichowska, A. W. (2024) · Current Issues in Molecular Biology · doi:10.3390/cimb46060367 · Cited by 14
Deficiency of Clusterin Inhibits Neointimal Hyperplasia After Vascular Injury
Shirasawa, T., Miyata, M., Eto, H., Hamada, N., Akasaki, Y., Miyauchi, T., Furusho, Y., Orihara, K., Hamasaki, S., Aronow, B. J., et al. (2009) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.1917 · Cited by 14
Rubenstein, M., Tsui, P. T., & Guinan, P. (2009) · Medical Oncology · doi:10.1007/s12032-009-9254-4 · Cited by 14
Wang, Y., Qin, X., & Paudel, H. K. (2017) · Neurobiology of Disease · doi:10.1016/j.nbd.2017.04.003 · Cited by 15
Vange, P., Bruland, T., Doseth, B., Fossmark, R., de Sousa, M. M. L., Beisvåg, V., Sørdal, Ø. F., Qvigstad, G., Waldum, H. L., Sandvik, A. K., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0184514 · Cited by 14
Chun, Y. (2014) · Journal of Toxicology and Environmental Health · doi:10.1080/15287394.2014.951760 · Cited by 14
Synthetic Nucleic Acids as Potential Therapeutic Tools for Treatment of Bladder Carcinoma
Fuessel, S., Meye, A., Kraemer, K., Kunze, D., Hakenberg, O. W., & Wirth, M. P. (2006) · European Urology · doi:10.1016/j.eururo.2006.07.045 · Cited by 14
Prochnow, H., Gollan, R., Rohne, P., Hassemer, M., Koch-Brandt, C., & Baiersdörfer, M. (2013) · PLoS ONE · doi:10.1371/annotation/48cea21c-d035-4757-bf42-c97028306f11 · Cited by 14
Shabestari, M. G., Shabestari, Y. R., Landin, M. A., Pepaj, M., Cleland, T. P., Reseland, J. E., & Eriksen, E. F. (2020) · International Journal of Rheumatic Diseases · doi:10.1111/1756-185x.13843 · Cited by 13
Hong, S., Lee, J., Kim, M. J., Moon, S. J., Kwon, H., Park, S. E., Rhee, E., & Lee, W. (2020) · Endocrinology and Metabolism · doi:10.3803/enm.2020.768 · Cited by 13
Sun, H.-Y., Chen, T., Tan, Y.-C., Wang, C.-H., & Young, K.-C. (2021) · Communications Biology · doi:10.1038/s42003-021-02093-2 · Cited by 13
Self-citationClusterin is associated with spontaneous breast cancer in TA2 mice
Sun, B., Zhang, S., Zhang, D., Liu, Y., Li, Y., Zhe, R., Zhu, Y., & Jia, X. (2007) · FEBS Letters · doi:10.1016/j.febslet.2007.06.021 · Cited by 13
Transcriptome‐Based Analysis of Molecular Pathways for Clusterin Functions in Kidney Cells
Dairi, G., Guan, Q., Roshan‐Moniri, M., Collins, C. C., Ong, C. J., Gleave, M. E., Nguan, C. Y. C., & Du, C. (2016) · Journal of Cellular Physiology · doi:10.1002/jcp.25415 · Cited by 13
Porcelli, L., Iacobazzi, R. M., Quatrale, A. E., Bergamini, C., Denora, N., Crupi, P., Antonacci, D., Mangia, A., Simone, G., Silvestris, N., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.15139 · Cited by 13
Metadata
- Authors
- Zhang, H., Kim, J. K., Edwards, C. A., Xu, Z., Taichman, R., & Wang, C.-Y.
- Affiliations
- University of Michigan (US)
- Corresponding author
- Wang, Cun-Yu
- Venue
- Nature Cell Biology
- Published
- 2005-08-21
- Volume
- 7
- Issue
- 9
- Pages
- 909-915
- ISSN
- 1465-7392 (ISSN-L)
- 1476-4679
- OpenAlex
- W2093107372
- Cited by
- 453
- References
- 27
- Citations by year
- 2026: 5 · 2025: 7 · 2024: 13 · 2023: 18 · 2022: 19 · 2021: 22 · 2020: 21 · 2019: 16 · 2018: 19 · 2017: 16 · 2016: 18 · 2015: 20 · 2014: 24 · 2013: 27 · 2012: 31
- FWCI
- 10.73
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Cell Biology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- Army Research Office
- Topics
- Health Sciences › Medicine › Oncology › Clusterin in disease pathology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Life Sciences › Immunology and Microbiology › Immunology › Biomarkers in Disease Mechanisms
- Keywords
- clusterin, apoptosis inhibition, Bax activation, Bax oligomerization, cytochrome c release, caspase activation, c-Myc, oncogenic transformation, tumor progression, chemosensitization, prostate cancer, breast cancer, squamous cell carcinoma, mitochondrial apoptosis
- MeSH terms
- Animals, Antineoplastic Agents, Cell Transformation, Neoplastic, Glycoproteins, Humans, Mitochondria, Neoplasms, Protein Conformation, Proto-Oncogene Proteins c-myc, Apoptosis, Molecular Chaperones, Drug Resistance, Neoplasm, Proto-Oncogene Proteins c-bcl-2, Caspases, Cytochromes c, Cell Line, Tumor, bcl-2-Associated X Protein, Clusterin, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review